|
1
|
Park JR, Bagatell R, London WB, Maris JM,
Cohn SL, Mattay KK and Hogarty M: COG Neuroblastoma Committee:
Children's Oncology Group's 2013 blueprint for research:
Neuroblastoma. Pediatr Blood Cancer. 60:985–993. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bell E, Chen L, Liu T, Marshall GM, Lunec
J and Tweddle DA: MYCN oncoprotein targets and their therapeutic
potential. Cancer Lett. 293:144–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schulte JH, Schowe B, Mestdagh P, Kaderali
L, Kalaghatgi P, Schlierf S, Vermeulen J, Brockmeyer B, Pajtler K,
Thor T, et al: Accurate prediction of neuroblastoma outcome based
on miRNA expression profiles. Int J Cancer. 127:2374–2385. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fontana L, Fiori ME, Albini S, Cifaldi L,
Giovinazzi S, Forloni M, Boldrini R, Donfrancesco A, Federici V,
Giacomini P, et al: Antagomir-17-5p abolishes the growth of
therapy-resistant neuroblastoma through p21 and BIM. PLoS One.
3:e22362008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu H, Du L, Nagabayashi G, Seeger RC and
Gatti RA: ATM is down-regulated by N-Myc-regulated microRNA-421.
Proc Natl Acad Sci USA. 107:1506–1511. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Buckley PG, Alcock L, Bryan K, Bray I,
Schulte JH, Schramm A, Eggert A, Mestdagh P, De Preter K,
Vandesompele J, et al: Chromosomal and microRNA expression patterns
reveal biologically distinct subgroups of 11q- neuroblastoma. Clin
Cancer Res. 16:2971–2978. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Y and Stallings RL: Differential
patterns of microRNA expression in neuroblastoma are correlated
with prognosis, differentiation, and apoptosis. Cancer Res.
67:976–983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shohet JM, Ghosh R, Coarfa C, Ludwig A,
Benham AL, Chen Z, Patterson DM, Barbieri E, Mestdagh P, Sikorski
DN, et al: A genome-wide search for promoters that respond to
increased MYCN reveals both new oncogenic and tumor suppressor
microRNAs associated with aggressive neuroblastoma. Cancer Res.
71:3841–3851. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
11
|
Wei JS, Song YK, Durinck S, Chen QR, Cheuk
AT, Tsang P, Zhang Q, Thiele CJ, Slack A, Shohet J, et al: The MYCN
oncogene is a direct target of miR-34a. Oncogene. 27:5204–5213.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lovén J, Zinin N, Wahlström T, Müller I,
Brodin P, Fredlund E, Ribacke U, Pivarcsi A, Påhlman S and
Henriksson M: MYCN-regulated microRNAs repress estrogen receptor-α
(ESR1) expression and neuronal differentiation in human
neuroblastoma. Proc Natl Acad Sci USA. 107:1553–1558. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Haug BH, Henriksen JR, Buechner J, Geerts
D, Tømte E, Kogner P, Martinsson T, Flægstad T, Sveinbjørnsson B
and Einvik C: MYCN-regulated miRNA-92 inhibits secretion of the
tumor suppressor DICKKOPF-3DKK3) in neuroblastoma. Carcinogenesis.
32:1005–1012. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Buechner J, Tømte E, Haug BH, Henriksen
JR, Løkke C, Flægstad T and Einvik C: Tumour-suppressor microRNAs
let-7mir-101 target the proto-oncogene MYCN and inhibit cell
proliferation in MYCN-amplified neuroblastoma. Br J Cancer.
105:296–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bray I, Bryan K, Prenter S, Buckley PG,
Foley NH, Murphy DM, Alcock L, Mestdagh P, Vandesompele J, Speleman
F, et al: Widespread dysregulation of MiRNAs by MYCN amplification
and chromosomal imbalances in neuroblastoma: Association of miRNA
expression with survival. PLoS One. 4:e78502009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schulte JH, Horn S, Otto T, Samans B,
Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L,
Buettner R, et al: MYCN regulates oncogenic MicroRNAs in
neuroblastoma. Int J Cancer. 122:699–704. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Olive V, Jiang I and He L: mir-17-92, a
cluster of miRNAs in the midst of the cancer network. Int J Biochem
Cell Biol. 42:1348–1354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chagnovich D, Fayos BE and Cohn SL:
Differential activity of ELAV-like RNA-binding proteins in human
neuroblastoma. J Biol Chem. 271:33587–33591. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lazarova DL, Spengler BA, Biedler JL and
Ross RA: HuD, a neuronal-specific RNA-binding protein, is a
putative regulator of N-myc pre-mRNA processing/stability in
malignant human neuroblasts. Oncogene. 18:2703–2710. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Grandinetti KB, Spengler BA, Biedler JL
and Ross RA: Loss of one HuD allele on chromosome #1p selects for
amplification of the N-myc proto-oncogene in human neuroblastoma
cells. Oncogene. 25:706–712. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Walton JD, Kattan DR, Thomas SK, Spengler
BA, Guo HF, Biedler JL, Cheung NK and Ross RA: Characteristics of
stem cells from human neuroblastoma cell lines and in tumors.
Neoplasia. 6:838–845. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schulte JH, Marschall T, Martin M,
Rosenstiel P, Mestdagh P, Schlierf S, Thor T, Vandesompele J,
Eggert A, Schreiber S, et al: Deep sequencing reveals differential
expression of microRNAs in favorable versus unfavorable
neuroblastoma. Nucleic Acids Res. 38:5919–5928. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
